Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen
- 28 August 1993
- journal article
- Published by Elsevier in The Lancet
- Vol. 342 (8870) , 518-521
- https://doi.org/10.1016/0140-6736(93)91646-4
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Biochemical markers of hepatic fibrosisClinical Biochemistry, 1991
- Analysis of serial measurements in medical research.BMJ, 1990
- Growth velocity, growth hormone therapy, and serum concentrations of the amino-terminal propeptide of type III procollagenThe Journal of Pediatrics, 1989
- Aminoterminal Propeptide of Type III Procollagen is Cleared from the Circulation by Receptor-Mediated Endocytosis in Liver Endothelial CellsCollagen and Related Research, 1988
- Serum type III procollagen and basement membrane proteins as noninvasive markers of hepatic pathology in Indian childhood cirrhosisHepatology, 1987
- Liver Disease after Human Marrow TransplantationSeminars in Liver Disease, 1987
- Variation in serum Type III procollagen peptide with age in healthy subjects and its comparative value in the assessment of disease activity in children and adults with chronic active hepatitis*European Journal of Clinical Investigation, 1985
- Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing FactorsHepatology, 1984